ERIC HARALSON: Open Payments
NPI 1871961797 · HENDERSON, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,033 in 53 payments from 22 companies in 2025. Trend: 2023 $1,077 · 2024 $772 · 2025 $1,033
Food & beverage: $1,033
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 13 | $222 |
| AstraZeneca Pharmaceuticals LP | 6 | $157 |
| Novo Nordisk Inc | 8 | $147 |
| Mannkind Corporation | 3 | $55 |
| Abbott Laboratories | 2 | $47 |
| SHIELD THERAPEUTICS INC | 2 | $40 |
| PFIZER INC. | 2 | $38 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $35 |
| ABBVIE INC. | 2 | $32 |
| Agios Pharmaceuticals, Inc. | 1 | $27 |
Products named: CAPLYTA, AIRSUPRA, Wegovy, AFREZZA, FREESTYLE LIBRE 3, ACCRUFER, ELIQUIS, Kerendia.
Industry payments across NV — which companies pay providers there.
